Search research articles
Contact Us
Filters
Showing results (211-220 of 250) with videos related to
Page
of 25
Sort By:
Transplantation and Cellular Therapy
|
November 5, 2025
National Landscape of Logistical and Nonmedical Requirements for Transplantation and Cellular Therapy
Hannah R Abrams, Helene Starks, Lindsey Bandini, et al.
Environmental Management
|
November 17, 2016
Visions of Restoration in Fire-Adapted Forest Landscapes: Lessons from the Collaborative Forest Landscape Restoration Program
Lauren S Urgenson, Clare M Ryan, Charles B Halpern, et al.
Leukemia & Lymphoma
|
March 23, 2021
Effect of post-treatment MRD status on subsequent outcomes according to chemotherapy intensity in acute myeloid leukemia (AML)
Michael J Hochman, Megan Othus, Roland B Walter, et al.
Leukemia & Lymphoma
|
March 9, 2023
Poor post-induction outcomes in patients with acute myeloid leukemia previously treated with hypomethylating agents
Michelle Y Zhang, Megan Othus, Carole Shaw, et al.
Haematologica
|
July 11, 2019
Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia
Janghee Woo, Dae Ro Choi, Barry E Storer, et al.
Haematologica
|
July 11, 2020
Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility
Mary-Elizabeth M Percival, Megan Othus, Sarah Mirahsani, et al.
Leukemia
|
January 21, 2022
Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies
Noam E Kopmar, Megan Othus, Kelda M Gardner, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 5, 1981
New metabolites in isovaleric acidemia
R J Truscott, D Malegan, E McCairns, et al.
Leukemia
|
November 14, 2019
Need for routine examination of left ventricular ejection fraction in patients with AML
Hiba M Khan, Kelda M Gardner, Carole Shaw, et al.
Leukemia & Lymphoma
|
February 21, 2020
Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm
Raffaele Palmieri, Sarah A Buckley, Megan Othus, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 250) with videos related to
Sort By:
Page
of 25
Transplantation and Cellular Therapy
|
November 5, 2025
National Landscape of Logistical and Nonmedical Requirements for Transplantation and Cellular Therapy
Hannah R Abrams, Helene Starks, Lindsey Bandini, et al.
Environmental Management
|
November 17, 2016
Visions of Restoration in Fire-Adapted Forest Landscapes: Lessons from the Collaborative Forest Landscape Restoration Program
Lauren S Urgenson, Clare M Ryan, Charles B Halpern, et al.
Leukemia & Lymphoma
|
March 23, 2021
Effect of post-treatment MRD status on subsequent outcomes according to chemotherapy intensity in acute myeloid leukemia (AML)
Michael J Hochman, Megan Othus, Roland B Walter, et al.
Leukemia & Lymphoma
|
March 9, 2023
Poor post-induction outcomes in patients with acute myeloid leukemia previously treated with hypomethylating agents
Michelle Y Zhang, Megan Othus, Carole Shaw, et al.
Haematologica
|
July 11, 2019
Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia
Janghee Woo, Dae Ro Choi, Barry E Storer, et al.
Haematologica
|
July 11, 2020
Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility
Mary-Elizabeth M Percival, Megan Othus, Sarah Mirahsani, et al.
Leukemia
|
January 21, 2022
Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies
Noam E Kopmar, Megan Othus, Kelda M Gardner, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 5, 1981
New metabolites in isovaleric acidemia
R J Truscott, D Malegan, E McCairns, et al.
Leukemia
|
November 14, 2019
Need for routine examination of left ventricular ejection fraction in patients with AML
Hiba M Khan, Kelda M Gardner, Carole Shaw, et al.
Leukemia & Lymphoma
|
February 21, 2020
Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm
Raffaele Palmieri, Sarah A Buckley, Megan Othus, et al.
Page
of 25